|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/113 | (2006.01) |
| A61K 31/713 | (2006.01) | ||
| C07H 21/02 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 17/14 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 27/16 | (2006.01) |
| (11) | Number of the document | 1799269 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05788492.6 |
| Date of filing the European patent application | 2005-09-27 | |
| (97) | Date of publication of the European application | 2007-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-07 |
| (46) | Date of publication of the claims translation | 2016-10-25 |
| (86) | Number | PCT/IL2005/001035 |
| Date | 2005-09-27 |
| (87) | Number | WO 2006/035434 |
| Date | 2006-04-06 |
| (30) | Number | Date | Country code |
| 613991 P | 2004-09-28 | US | |
| 658196 P | 2005-03-02 | US | |
| 703020 P | 2005-07-26 | US |
| (72) |
FEINSTEIN, Elena, IL
ZURR, Daniel, IL
EHRLICH, Shai, US
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Oligoribonukleotidai ir jų naudojimo būdai alopecijos, ūminio inkstų nepakankamumo ir kitų ligų gydymui |
| OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR TREATMENT OF ALOPECIA, ACUTE RENAL FAILURE AND OTHER DISEASES |
| Payment date | Validity (years) | Amount | |
| 2021-08-20 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-09-27 |